Page 2 - Medicines Control Authority Of Zimbabwe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ZIMBABWE has introduced Cabotegravir long-acting (CAB-LA), an injectable pre-exposure prophylaxis drug, to add to the HIV prevention regime in the country. The drug, an ARV designed to suppress any infection as it occurs, is for HIV-negative people who have a high risk of becoming infected with HIV. It is the third pre-exposure prophylaxis (PrEP) product…

Mashonaland eastIdah moyoMinistry of healthMedicines control authority of zimbabweTb programmeChild careMedicines control authoritySub saharan africa